ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
United Immunity and Xyphos, an Astellas Company, to Collaborate on Next Generation Nano-Immunotherapies for Cancer Treatment
January 15, 2021United Immunity, Co., Ltd. has entered into a joint research agreement as of December 2020 with Xyphos Biosciences, Inc., (California, US), a subsidiary of Astellas Pharma Inc. (Tokyo, Japan). -
Astellas has announced its acquisition of Xyphos for $665m
January 09, 2020Xyphos Biosciences will become a wholly owned subsidiary of Astellas Pharma following an acquisition made by the latter company. -
Astellas Acquires Xyphos Biosciences
January 06, 2020Astellas Pharma announced the company has acquired Xyphos Biosciences. With the acquisition Astellas will gain Xyphos' novel and proprietary ACCEL (Advanced Cellular Control through Engineered Ligands) technology platform.
Pharma Sources Insight January 2025
